Single award · contract

100M SARS-COV-2 MRNA-1273 Vaccine Doses

Award ID: W911QY20C0100

FY2020 · complete year · data as of 2026-07-12

A single federal award, with both ends of the trail linked.

$8.2B
Total award value

Award W911QY20C0100 is a contract from the Department of Defense to Modernatx, Inc., $8.2B obligated, FY2020 to FY2023, for 100M SARS-COV-2 MRNA-1273 Vaccine Doses. The work is performed in Massachusetts. It is classified as NAICS 325412 (Pharmaceutical Preparation Manufacturing) and PSC 6505 (Drugs and Biologicals). Source

Agency ›
Department of Defense
Source
awarded→$8.2B
Recipient ›
Modernatx, Inc.
Source
performed in→
State ›
Massachusetts
Source

Award details

Award typeContract
PIIDW911QY20C0100
Action date2020
Period36 mo
Awarding agencyDepartment of Defense →
RecipientModernatx, Inc. →
Place of performanceMassachusetts →
CategoryNAICS 325412PSC 6505
Competed?Not recordedSource
Total (exact)$8,204,906,278

More awards to Modernatx, Inc.

Moderna Therapeutics, Inc:advance the Development of an Mrna Vaccine for the…
awarded 2016$73M
All awards to this recipient →

More from Department of Defense

Contract HT940216C0001
awarded 2016$51.3B
SSN 802 and 803 Long Lead Time Material
awarded 2017$35.7B
LRIP Lot 12 Advance Acquisition Contract
awarded 2017$35.1B
Contract N0001902C3002
awarded 2001$34.2B
KC-X Modernization Program
awarded 2011$32B
All awards from this agency →
Why the labels? The graph is only worth anything if the links are trusted. Facts taken straight from a federal filing are Source; figures we calculate are Computed; links we infer (corporate parents, districts, similar contractors, connections between records) are Inferred, worded carefully, never asserted as fact and never a claim that one thing caused another. Spot an error? Tell us.